Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin

10 mg, oral tablet, once daily for 24 weeks of double-blind treatment period

5 mg, oral tablet, once daily for 24 weeks of double-blind treatment period

10 mg, oral tablet, once daily for 24 weeks of double-blind treatment period

5 mg, oral tablet, once daily for 24 weeks of double-blind treatment period

5 mg, oral tablet, once daily for 24 weeks of double-blinded treatment period, and for 16 weeks of open-label treatment period in Stratum A or 8 weeks of open-label treatment period in Stratum B

Stable dose of metformin immediate release/extended release (≥ 1500 mg/day or at a maximal tolerated dose) throughout the whole study period